[31] In February 2018, authorization was granted in the European Union, [16] [84] in March 2018 in Japan, [32] and in August 2019 in Australia
Jones JT, Haegeman A, Danchin EGJ, Gaur HS, Helder J, Jones MGK, et al
Although CntA/B may be responsible for some TMA formation by -proteobacteria intimately associated with the intestinal epithelium using oxygen that diffuses into the luminal content, because of its oxygen requirement, it is unlikely to be the primary physiologic source of l-carnitineTMA activity in the mostly anoxic luminal intestinal environment
4.2.1 Metformin Metformin demonstrated efficacy in blocking the increase of fatty acid transport protein CD36, along with aberrant ceramide and diacylglycerol content in the skeletal muscle of diabetic rats (126)
Fromenty B, Roden M